The aim of this core is to provide pathology services by experienced pathologists with a unique combination of extensive background in the pathology of lymphomas and breast tumors. All four projects will benefit from the Core. Having all pathology studies conducted by a specialized entity ran by expert pathologists will ensure that the same standards will be apply across the different projects. This will be critically Important for cell studies in vitro, which will benefit from uniform experimental protocols and interpretation. Project 3 and 4 will perform tumor studies in mice that require a dedicated Core. Indeed, the pathology services and facilities currently in place at Columbia University are not certified for mouse pathology and could not handle the samples in a timely manner. The Core will be ran by two experts pathologists;Drs. Bhagat and Szabolcs, lymphoma and breast cancer experts, respectively. Both have extensive experience in murine and human pathology and have been associated with several of the project leaders for years in collaborative and productive studies. Therefore, quality control is completely in place, as all procedures have been optimized, standardized and streamlined. Thus, we anticipate the most efficient usage of this core.

Public Health Relevance

Core C will conduct immunofluorescence studies in cells and the histopatholgical analysis of animals and tumors for all four projects of this program. Core C will be critical to the studies proposed in this program especially for animal studies in Projects 3 and 4.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA174653-01A1
Application #
8608851
Study Section
Special Emphasis Panel ()
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
1
Fiscal Year
2014
Total Cost
$188,901
Indirect Cost
$70,838
Name
Columbia University
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Yu, Tai-Yuan; Kimble, Michael T; Symington, Lorraine S (2018) Sae2 antagonizes Rad9 accumulation at DNA double-strand breaks to attenuate checkpoint signaling and facilitate end resection. Proc Natl Acad Sci U S A 115:E11961-E11969
Oh, Julyun; Lee, So Jung; Rothstein, Rodney et al. (2018) Xrs2 and Tel1 Independently Contribute to MR-Mediated DNA Tethering and Replisome Stability. Cell Rep 25:1681-1692.e4
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Schrank, Benjamin R; Aparicio, Tomas; Li, Yinyin et al. (2018) Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559:61-66
Gnügge, Robert; Oh, Julyun; Symington, Lorraine S (2018) Processing of DNA Double-Strand Breaks in Yeast. Methods Enzymol 600:1-24
Crowe, Jennifer L; Shao, Zhengping; Wang, Xiaobin S et al. (2018) Kinase-dependent structural role of DNA-PKcs during immunoglobulin class switch recombination. Proc Natl Acad Sci U S A 115:8615-8620
Gnügge, Robert; Symington, Lorraine S (2017) Keeping it real: MRX-Sae2 clipping of natural substrates. Genes Dev 31:2311-2312
Liu, Xiangyu; Shao, Zhengping; Jiang, Wenxia et al. (2017) PAXX promotes KU accumulation at DNA breaks and is essential for end-joining in XLF-deficient mice. Nat Commun 8:13816
Kato, Niyo; Kawasoe, Yoshitaka; Williams, Hannah et al. (2017) Sensing and Processing of DNA Interstrand Crosslinks by the Mismatch Repair Pathway. Cell Rep 21:1375-1385
Aparicio, Tomas; Gautier, Jean (2016) BRCA1-CtIP interaction in the repair of DNA double-strand breaks. Mol Cell Oncol 3:e1169343

Showing the most recent 10 out of 25 publications